Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion type Assertion NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_head.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion description "[The percentage of VDR+ EPCs correlated positively with VDRA therapy and 25(OH)D, and negatively with diabetes, C-reactive protein, hemoglobin and osteopontin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_provenance.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion evidence source_evidence_literature NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_provenance.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion SIO_000772 23485859 NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_provenance.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion wasDerivedFrom befree-20140225 NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_provenance.
- NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_assertion wasGeneratedBy ECO_0000203 NP625242.RALH4TkVvbp9LAYGYbeNU4c_ike30BBlK5O42K_CMXyCQ130_provenance.